drug · small molecule
patient view →brexpiprazole LAI
Phase 1updated 2mo agoby Bostal Drug Delivery Co Ltd🔗 ChEMBL
Phase 1community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 9 investigational indications.
targets
5-hydroxytryptamine receptor 2A5-hydroxytryptamine receptor 1AD(2) dopamine receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that